An interventional study of Fatigue protocol in Nutrition and Sports, sponsored by University of Maia. Not yet recruiting. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-15.
Sponsored by University of Maia · Not applicable, Interventional, and Other
Considering the promising effects observed and the scarce and incipient scientific background of SFN in sports, the present study aims to evaluate the effects of SFN supplementation on fatigue, EIMD and recovery in trained individuals. In particular, outcomes such as time to exhaustion (TTE), and perceptual questionnaires of muscle soreness, recovery, and fatigue will be assessed, aiming to explore the effectiveness of SFN.
1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.
This study's planned enrollment of 20 is below the median of 54 across 1,440 interventional studies indexed under Fatigue.
Browse Fatigue studies →University of Maia is the lead sponsor of 21 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Sulforaphane supplementation (Nomio)
Other: Fatigue protocol
Placebo intervention
Other: Fatigue protocol
Fatigue protocol comprising 6 sets of 30 seconds at 120% of velocity of maximal oxygen consumption
time to exhaustion
Time frame: 24 hours
Rating of Fatigue Scale
Time frame: Baseline, 30 minutes, 24 hours
Total Quality Recovery Scale
Time frame: Baseline, 30 minutes, 24 hours
Muscle soreness (Visual analogue scale)
Time frame: Baseline, 30 minutes, 24 hours
Rating of perceived exertion scale
Time frame: 30 minutes
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Maia